Equities

Faron Pharmaceuticals Oy

FARN:LSE

Faron Pharmaceuticals Oy

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)142.50
  • Today's Change0.00 / 0.00%
  • Shares traded17.54k
  • 1 Year change-35.27%
  • Beta-0.0354
Data delayed at least 20 minutes, as of Nov 22 2024 14:00 GMT.
More ▼

Key statistics

On Friday, Faron Pharmaceuticals Oy (FARN:LSE) closed at 142.50, 67.65% above the 52 week low of 85.00 set on Jun 20, 2024.
52-week range
Today
85.00Jun 20 2024307.38Dec 13 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open142.50
High156.00
Low142.50
Bid137.00
Offer167.00
Previous close142.50
Average volume7.54k
Shares outstanding104.62m
Free float71.34m
P/E (TTM)--
Market cap148.85m GBP
EPS (TTM)-0.3161 GBP
Data delayed at least 20 minutes, as of Nov 22 2024 14:00 GMT.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.